Valuation
- Market cap
- 3,465,000
- Revenue TTM
- $0
- Net income TTM
- $-25,080,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- -59.14
Trading
- Volume
- 1,610,800
- Avg volume
- 11,475,476
- Day's range
- $0.15 – $0.16
- Shares out
- 22,210,000
- Stochastic %K
- 8%
- Beta
- 0.02
- Analysts
- Strong Sell
- Price target
- $3.50
Company profile
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC ca...
Show more
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 949 348 1188
- Website
- https://adagiomedical.com
- Address
- 26051 Merit Circle, Suite 102, Laguna Hills, United States
Latest news
No headlines yet.
